EUVIMEDEUVIMED entdecken
Crossref

Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma

Jing Luo, Mingwei Li, Di Zhao, Hong Chen, Junkai Huang, Mengke Sun, Qianyu Zhu, Qi Guo, Sicheng Song, Qianshu Yuan, Hui Li, Fengtong Li und 5 weitere

International Immunopharmacology · 2026-03 · 172 · 116166

DOI: 10.1016/j.intimp.2026.116166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-03. Verfasst von Jing Luo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, Chi…. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type II, Skin, Scleroderma, Systemic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Tianjin Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleroderma is a connective tissue disorder marked by chronic inflammation and progressive skin fibrosis. Abnormal activation of fibroblasts (FBs) and deposition of collagen in the extracellular matrix (ECM) are the key to the progression of scleroderma. While FBs activation has been attributed to the dysfunction of keratinocytes (KCs) and immune cells, the crosstalk among these cells is considered critical for scleroderma progression. Recent evidence indicates that inducible nitric oxide synthase (iNOS) is highly expressed in scleroderma lesions, and iNOS contributes to the progression of dermatoses. Nevertheless, the specific role of iNOS in scleroderma remains to be fully elucidated. We utilized a bleomycin (BLM)-induced scleroderma model in wildtype (WT) and iNOS knockout (iNOS KO) mice to investigate the function of iNOS in scleroderma. We demonstrated that iNOS deficiency alleviated scleroderma progression, inhibiting inflammatory factor expression in KCs and neutrophils (Neus) infiltration. Subsequently, we stimulated FBs with TNF-α and IL-1β, which are mainly expressed by KCs and Neus, and confirmed that iNOS deletion attenuated FBs activation. We also revealed that iNOS inhibitors significantly attenuated the severity of scleroderma lesions. Our study collectively unveils a pivotal role of iNOS in scleroderma, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IISkinScleroderma, SystemicAnimalsMice, KnockoutBleomycinFibrosisFibroblastsMiceNeutrophilsKeratinocytesHumansDisease Models, AnimalMice, Inbred C57BLInflammationTumor Necrosis Factor-alphaInterleukin-1beta

Stichwörter der Autor:innen

FibroblastsInducible nitric oxide synthaseIntercellular crosstalkKeratinocytesNeutrophilsScleroderma

Substanzen

Nitric Oxide Synthase Type IIBleomycinNos2 protein, mouseTumor Necrosis Factor-alphaInterleukin-1beta

Autor:innen und Institutionen

  • Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China.
  • Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
  • Department of Ophthalmology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, No. 354, Bei Road, Hongqiao District, Tianjin, China. Electronic address: xingweibin111@163.com.
  • Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China; Department of Orbital Research Institute, the Second Hospital of T…

Förderung

  • Tianjin Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Luo, J., Li, M., Zhao, D., Chen, H., Huang, J., Sun, M., Zhu, Q., Guo, Q., Song, S., Yuan, Q., Li, H., Li, F., Li, Y., Zhang, B., Su, L., Xing, W., & Hu, L. (2026). Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma. International Immunopharmacology, 172, 116166. https://doi.org/10.1016/j.intimp.2026.116166

Vancouver

Luo J, Li M, Zhao D, Chen H, Huang J, Sun M, et al. Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma. International Immunopharmacology. 2026;172:116166. doi:10.1016/j.intimp.2026.116166

BibTeX
@article{Luo2026,
  author = {Luo, Jing and Li, Mingwei and Zhao, Di and Chen, Hong and Huang, Junkai and Sun, Mengke and Zhu, Qianyu and Guo, Qi and Song, Sicheng and Yuan, Qianshu and Li, Hui and Li, Fengtong and Li, Yingxi and Zhang, Bingxin and Su, Long and Xing, Weibin and Hu, Lizhi},
  title = {Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {172},
  pages = {116166},
  doi = {10.1016/j.intimp.2026.116166}
}
Kostenlos starten →